Julie Lesage

article Singh SK, Jaure A, Gill MP, Johnston O, Gill J, Caton N, Pâquet M, John P, Ogniben A, Chritchley S, Dipchand C, Pike P, Shamseddin MK, Bau J, Gourishankar S, Lesage J, Mainra R, Yohanna S, Connaughton DM, Gogan N, Storsley L, Redditt V, Duff M, Cazzolli R, Dominello A, Silva JR, Scholes-Robertson N, Sinka V, Gill JS

Recommendations for Living Kidney Donor Follow-Up in Canada

Clin Transplant 40 (5), 2026.

DOI PUBMED

article Béland MA, Lapointe I, Côté I, Lesage J, Houde I, Wagner E, Riopel J, Latulippe E, Désy O, De Serres SA

HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies

Front Immunol 15 2024.

DOI PUBMED

article Désy O, Thivierge MP, Béland S, Desgagnés JS, Bouchard-Boivin F, Gama A, Houde I, Lapointe I, Côté I, Lesage J, De Serres SA

A Risk Score Using a Cell-based Assay Predicts Long-term Over-immunosuppression Events in Kidney Transplant Recipients

Transplantation 109 (7), 2025.

DOI PUBMED

Chercheuse associée
Axe Endocrinologie et néphrologie

Publications

Recommendations for Living Kidney Donor Follow-Up in Canada

Clin Transplant 40 (5), 2026.

HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies

Front Immunol 15 2024.

A Risk Score Using a Cell-based Assay Predicts Long-term Over-immunosuppression Events in Kidney Transplant Recipients

Transplantation 109 (7), 2025.